Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Can Silo Pharma (SILO) Stock Be a Hot Nasdaq Debut?

In today's session, investors in Silo Pharma and SILO stock are seeing significant losses, as this psychedelics company is officially listed.

ATXI Stock Alert: What to Know as Avenue Therapeutics Soars 150%

Today, investors in Avenue Therapeutics and ATXI stock have seen impressive gains, as momentum builds for this micro-cap stock.

When Will the Stock Market Recover in 2022? 2023?

Many investors are hoping a stock market recovery will be underway, as the market tests June lows once again in today's session.

NIO Stock Alert: Nio Just Made a Big Lithium Bet

Today, investors in EV maker Nio and NIO stock are cheering an announcement of a strategic investment in an Australian lithium miner.

3 Cryptos to Buy on the Dip, or You’ll be Kicking Yourself Later

Here are three top cryptos to buy on the dip for long-term growth as investors look for more attractive valuations in this current market.